Int J Med Sci 2013; 10(11):1595-1601. doi:10.7150/ijms.6506
Eight-Year Seroprevalence of HBV, HCV and HIV in Diyarbakir Training and Research Hospital
Diyarbakır Training and Research Hospital, Department of Microbiology, Diyarbakır, Turkey.
Turhanoğlu M, Onur A, Bilman FB, Ayaydın Z, Aktar GS. Eight-Year Seroprevalence of HBV, HCV and HIV in Diyarbakir Training and Research Hospital. Int J Med Sci 2013; 10(11):1595-1601. doi:10.7150/ijms.6506. Available from http://www.medsci.org/v10p1595.htm
Distribution of HBV, HCV and HIV results of the inpatients or outpatients, who had been treated for various diagnoses in Diyarbakır Training and Research Hospital between 2005 and 2012, among years was investigated.
Files of the patients, who had been treated as inpatient or outpatient 992. to any diagnosis between 01/01/2005 and 31/12/2012 in the clinics or policlinics of Diyarbakır 581 due Training and Research Hospital, were retrospectively reviewed using patient file database. Serum samples (235.534 for HBsAg, 196.727 for Anti-HBs antibody, 98.497 for HBeAg, 97.417 for Anti-HBe antibody, 225.483 for HCV and 138.923 for HIV) of these patients, which had been processed in microbiology laboratory, were studied by chemiluminescence technique using Roche E-170 (Modular Analytics System) device.
Prevalence rates between 2005 and 2012 were as follows: 15.9%-9% for HBsAg, 32.9%-52.3% for Anti-HBs, 2.5%-1.8% for HBeAg, 30.4%-25.2% for Anti-HBe, 1%-0.7% for Anti-HCV, and 0.1%-1% for Anti-HIV. Increase in Anti-HBs prevalence is the successful outcome of routine immunization in population. This suggests that, governmental policies focused on this subject have resulted in successful outcomes and that people also take care about this.
A prevalence rate decreasing to 9% from 15.9% for HBsAg and prevalence rate increasing to 52.3% from 32.9% for Anti-HBs antibody positivity in 8-year period in our region is quite meaningful. Such favorable developments in our region are of great valuable in terms of indicating to what extent could struggle against HBV is controlled by education and awareness.
Keywords: HBV, HCV, HIV, Seroprevalence.